Almitas Capital’s Safeguard Scientifics, Inc. SFE Stock Holding History

Almitas Capital’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-257,491	Closed	-$257K	–	125
2023 Q3	$257K	Sell	257,491 -539,141	-68%	-$701K	0.12%	73
2023 Q2	$1.23M	Hold	796,632	–	–	0.52%	43
2023 Q1	$1.37M	Hold	796,632	–	–	0.65%	43
2022 Q4	$2.47M	Buy	796,632 +83,187	+12%	+$280K	1.14%	22
2022 Q3	$2.66M	Hold	713,445	–	–	1.99%	15
2022 Q2	$2.66M	Buy	713,445 +12,425	+2%	+$51.9K	1.38%	19
2022 Q1	$3.66M	Buy	+701,020	New	+$4.24M	2.18%	14
2020 Q4	$4.1M	Hold	642,753	–	–	4.16%	7
2020 Q3	$3.52M	Hold	642,753	–	–	4.78%	6
2020 Q2	$4.5M	Sell	642,753 -7,490	-1%	-$47.4K	5.61%	7
2020 Q1	$3.61M	Hold	650,243	–	–	7.99%	2
2019 Q4	$7.14M	Buy	650,243 +10,968	+2%	+$125K	6.22%	3
2019 Q3	$7.25M	Sell	639,275 -3,517	-0.5%	-$41.9K	7.75%	3
2019 Q2	$7.76M	Buy	642,792 +239,794	+60%	+$2.81M	8.05%	3
2019 Q1	$4.37M	Buy	402,998 +156,580	+64%	+$1.59M	3.12%	8
2018 Q4	$2.12M	Buy	+246,418	New	+$2.15M	1.43%	19

Other funds holding SFE

CCM

Contrarian Capital Management Greenwich, Connecticut $306M AUM 23.06% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Almitas Capital's SFE Position: Q4 2023 in Review

Almitas Capital sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2023, closing a stake of 257,491 shares — an estimated $257K sold.

Almitas Capital first reported a position in SFE in Q4 2018 and held it in 16 quarters. The position peaked at $7.76M in Q2 2019. 39 funds tracked by Wall St. Rank hold SFE as of Q4 2023.

Almitas Capital reported no remaining Safeguard Scientifics, Inc. position as of Q4 2023 after selling out during the quarter.
Almitas Capital sold 257,491 Safeguard Scientifics, Inc. shares in Q4 2023, an estimated $257K.
Almitas Capital first reported a position in Safeguard Scientifics, Inc. in Q4 2018 and held it in 16 quarters.
Almitas Capital's Safeguard Scientifics, Inc. position peaked at $7.76M in Q2 2019.
39 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2023.

Based on Almitas Capital's 13F filing for Q4 2023, filed 14 Feb 2024.